Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Equity (2021 - 2025)

Historic Return on Equity for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 0.25%.

  • Legend Biotech's Return on Equity fell 800.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.0% for FY2024, which is 5200.0% up from last year.
  • Legend Biotech's Return on Equity amounted to 0.25% in Q3 2025, which was down 800.0% from 0.33% recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Return on Equity registered a high of 0.12% during Q2 2024, and its lowest value of 1711.13% during Q2 2021.
  • In the last 5 years, Legend Biotech's Return on Equity had a median value of 0.35% in 2023 and averaged 107.69%.
  • In the last 5 years, Legend Biotech's Return on Equity soared by 8373100bps in 2021 and then tumbled by -2100bps in 2025.
  • Legend Biotech's Return on Equity (Quarter) stood at 1.25% in 2021, then skyrocketed by 31bps to 0.87% in 2022, then skyrocketed by 67bps to 0.29% in 2023, then skyrocketed by 38bps to 0.18% in 2024, then plummeted by -41bps to 0.25% in 2025.
  • Its Return on Equity was 0.25% in Q3 2025, compared to 0.33% in Q2 2025 and 0.22% in Q1 2025.